|
Mar 22
|
Q4 2023 Fennec Pharmaceuticals Inc Earnings Call
|
|
Mar 21
|
Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update
|
|
Mar 19
|
Fennec (FENC) Signs Licensing Deal With Norgine, Stock Up
|
|
Mar 19
|
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024
|
|
Mar 18
|
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
|
|
Mar 13
|
Analysts Are Optimistic We'll See A Profit From Fennec Pharmaceuticals Inc. (NASDAQ:FENC)
|
|
Jan 6
|
Insider Sell: CFO Robert Andrade Sells 30,000 Shares of Fennec Pharmaceuticals Inc
|
|
Dec 6
|
With 31% stake, Fennec Pharmaceuticals Inc. (NASDAQ:FENC) seems to have captured hedge funds investors' interest
|
|
Dec 5
|
Fennec Announces Incremental $5 Million Investment from Petrichor
|